Pyxis Oncology Appoints Lara Sullivan, M.D. as Chief Executive Officer and Director
Boston, Mass., December 11, 2019 – Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor microenvironment, today announced the appointment of Lara Sullivan, M.D. as Chief Executive Officer and Director. She succeeds Longwood General Partner and founding Chief Executive Officer David Steinberg, […]
Pyxis Oncology Appoints Lara Sullivan, M.D. as Chief Executive Officer and Director Read More »
